Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
LKB1/STRAD promotes axon initiation during neuronal polarization.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Iran mass produces MS drug Ziferon
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Statement on a nonproprietary name adopted by the USAN Council
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Interferon-beta(1b) treatment in neuromyelitis optica.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Pages
« first
‹ previous
…
91
92
93
94
95
96
97
98
99
…
next ›
last »